Evidence map›Paper›PMID 32725280›Full record

ArticleDiabetologia2020

Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study.

Anna-Maaria Auvinen, Kaisu Luiro, Jari Jokelainen, Ilkka Järvelä, Mikael Knip, Juha Auvinen, Juha S Tapanainen

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06064552 unknown statusnot on this mapstarted 2023, after this paper: background citation

Screening For First Trimester's Hyperglycemia in High and Low Risk Pregnancy

TypeobservationalSponsorSohag UniversityRan2023 to 2024Enrolled100ConditionsScreening for Hyperglycemia in First Trimester in High and Low Risk PregnancyArmsblood sugar
NCT07446205 narecruitingnot on this mapstarted 2026, after this paper: background citation

Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk

TypeinterventionalSponsorUniversity of HawaiiRan2026 to 2027Enrolled50ConditionsGestational Diabetes Mellitus (GDM), PregnancyArmsFermented Poi
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anna-Maaria AuvinenDepartment of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland.
Kaisu LuiroDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO 140 (Haartmaninkatu 2E), 00029, Helsinki, Finland.ORCID 0000-0003-0736-2891
Jari JokelainenCenter for Life Course Health Research, University of Oulu, Oulu, Finland.ORCID 0000-0003-4629-0560
Ilkka JärveläDepartment of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland.
Mikael KnipChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-0474-0033
Juha AuvinenCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Juha S TapanainenDepartment of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland. juha.tapanainen@helsinki.fi.ORCID 0000-0002-3139-9128
Oulu University Hospital · FIUniversity of Helsinki · FIKuopio University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThe aim of this work was to examine the progression to type 1 and type 2 diabetes after gestational diabetes mellitus (GDM) in a 23 year follow-up study.

methodsWe carried out a cohort study of 391 women with GDM diagnosed by an OGTT or the use of insulin treatment during pregnancy, and 391 age- and parity-matched control participants, who delivered in 1984-1994 at the Oulu University Hospital, Finland. Diagnostic cut-off levels for glucose were as follows: fasting, ≥4.8 mmol/l; 1 h, ≥10.0 mmol/l; and 2 h, ≥8.7 mmol/l. Two follow-up questionnaires were sent (in 1995-1996 and 2012-2013) to assess the progression to type 1 and type 2 diabetes. Mean follow-up time was 23.1 (range 18.7-28.8) years.

resultsType 1 diabetes developed (5.7%) during the first 7 years after GDM pregnancy and was predictable at a 2 h OGTT value of 11.9 mmol/l during pregnancy (receiver operating characteristic analysis: AUC 0.91, sensitivity 76.5%, specificity 96.0%). Type 2 diabetes increased linearly to 50.4% by the end of the follow-up period and was moderately predictable with fasting glucose (AUC 0.69, sensitivity 63.5%, specificity 68.2%) at a level of 5.1 mmol/l (identical to the fasting glucose cut-off recommended by the International Association of Diabetes and Pregnancy Study Groups [IADPSG) and WHO]). CONCLUSIONS/

interpretationAll women with GDM should be intensively monitored for a decade, after which the risk for type 1 diabetes is minimal. However, the incidence of type 2 diabetes remains linear, and therefore individualised lifelong follow-up is recommended.

Indexed as

AdultCase-Control StudiesCohort StudiesDiabetes, GestationalDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucose Tolerance TestHumansMiddle AgedPregnancyRisk FactorsGDMInsulinOGTTPredictionType 1 diabetesType 2 diabetes

Identifiers

PMID32725280
PMCPMC7476985
OpenAlexW3046026969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.